Call Options

22 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$111.15 - $128.97 $6,335 - $7,351
-57 Reduced 37.5%
95 $10,000
Q2 2024

Jul 31, 2024

SELL
$123.8 - $132.96 $2,476 - $2,659
-20 Reduced 11.63%
152 $18,000
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $3,963 - $4,618
35 Added 25.55%
172 $22,000
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $2,504 - $2,725
-25 Reduced 15.43%
137 $14,000
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $823 - $914
-8 Reduced 4.71%
162 $16,000
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $3,475 - $3,788
-32 Reduced 15.84%
170 $19,000
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $20,793 - $23,201
202 New
202 $21,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $9,129 - $10,255
108 Added 41.54%
368 $20,000
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $667 - $757
-8 Reduced 2.99%
260 $38,000
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $2,572 - $2,884
35 Added 15.02%
268 $43,000
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $3,252 - $4,074
45 Added 23.94%
233 $38,000
Q3 2021

Oct 28, 2021

SELL
$71.68 - $78.83 $2,795 - $3,074
-39 Reduced 17.18%
188 $29,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $8,999 - $9,954
128 Added 129.29%
227 $17,000
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $275 - $324
4 Added 4.21%
99 $4,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $1,937 - $2,150
27 Added 39.71%
95 $14,000
Q3 2020

Nov 06, 2020

BUY
$73.18 - $82.95 $439 - $497
6 Added 9.68%
68 $15,000
Q2 2019

Aug 12, 2019

SELL
$69.84 - $81.59 $977 - $1,142
-14 Reduced 18.42%
62 $36,000
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $3,548 - $4,047
51 Added 204.0%
76 $49,000
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $173 - $203
-3 Reduced 10.71%
25 $5,000
Q4 2017

Feb 06, 2018

BUY
$51.62 - $61.64 $51 - $61
1 Added 3.7%
28 $1,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $117 - $126
2 Added 8.0%
27 $1,000
Q2 2017

Aug 11, 2017

BUY
N/A
25
25 $3,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.